Lok Sabha Question No. 2133 (UNSTARRED), answered on 2020-09-23
Subject: Indigenous manufacturing of Medical Equipments
Ministry: HEALTH AND FAMILY WELFARE
Asked by: Hanuman Beniwal, Pocha Brahmananda Reddy, Devji Mansingram Patel

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

## LOK SABHA UNSTARRED QUESTION NO. 2133 TO BE ANSWERED ON 23 RD SEPTEMBER, 2020

## INDIGENOUS MANUFACTU RING OF MEDICAL EQUIPMENTS

## 2133. SHRI HANUMAN BENIWAL: SHRI POCHA BRAHMANANDA REDDY: SHRI DEVJI M. PATEL:

Will the Minister of HEALTH AND FAMILY WELFARE

be pleased to state:

- (a)  whether  Government  is  aware  that  most  of  the medical  equipment  being  used  in  the country  are imported,  if  so,  the  details  thereof and  the  category  of medical  equipments imported from other countries at present;
- (b) the scheme formulated by the Government to make India self reliant in the manufacturing of medical equipment including ventilators, surgical items etc. and to in re se the production of the same in the country;
- (c)  the  total  amount  allocated  for  the  development of  manufacturing  and  research infrastructure for medical equipments and medicine, State/UT - wise including Rajasthan; and
- (d)  whether  India  is  also  dependent  on the  import  of raw  materials  for  bulk  drug manufacturing,  if  so,  the details  thereof  and  the  steps  taken  to  reduce  the  import of  raw materials used for the manufacturing of medicines?

## ANSWER THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE

(SHRI ASHWINI KUMAR CHOUBEY)

- (a): India  is  86%  import - dependent  on  Medical  Devices/equipments.  The  various segments of devices/equipments imported are Electronics Equipment, Surgical Instrumen Conusumable & Disposables, IVD Reagent and Implants.
- (b): Various schemes/initiatives have been formulated to promote domestic manufacturin of medical devices/equipments and attract large investment in the sector:
- I. National Biopharma Mission.
- II. DBT -AMTZ COMManD [Covid - 19 Medtech Manufacturing Development] Consortia  launched  by  Department  of  Biotechnology  (DBT)  with  Andhra  Pradesh Med - tech Zone (AMTZ).
- III. National  Biomedical  Resource  Indigenisation  Consortium  constituted  as  a  Publ Private Partnership.
- IV. BioNEST scheme of Biotechnology Industry Research Assistan ce Council (BIRAC).
- V. Production  Linked  Incentive  Scheme  for  Promoting  Domestic  Manufacturing  of Medical Devices.
- VI. Scheme for "Promotion of Medical Devices Parks".
- (c): Under the National Biopharma Mission, a total investment of Rs.148.79 crores has been  committed  for  establishment  of  infrastructure  and  facilities  for  manufacturin testing  of  medical  devices.  A  total  of  9  such  facilities  have  been  funded.  The  st - wise distribution is as below:
- (d) : Indian pharma industry is reliant on bulk drug imports amounting to around USD 3.5 bn (approximately Rs.25752 crore) a year based on the data of the last two years.

| States         |   Amount (Rs. in |
|----------------|------------------|
| Andhra Pradesh |            83.2  |
| Karnataka      |            12.7  |
| Maharashtra    |            11.09 |
| Telangana      |            22.71 |
| Uttar Pradesh  |            19.09 |

The imports are mainly in Key Staring Materials (KSMs), drug intermediates an some of the Active Pharmaceutical Ingredients (APIs).

The  Government  has  approved  the  following  schemes  to  promote  domestic manufacturing in the sector:

- A. The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore during of five years.
- B. Production Linked Incentive (PLI) Scheme for promotion of do mestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications o 6,940 crore during a period of eight years.